Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catriona Goodlad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Postgraduate Medical Journal|August 3, 2013
The role of peritoneal dialysis in modern renal replacement therapyCatriona Goodlad, Edwina Brown
Seminars in Nephrology|March 29, 2011
Encapsulating peritoneal sclerosis: what have we learned?Catriona Goodlad, Edwina A Brown
American Journal of Nephrology|June 1, 2017
Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal DialysisAniema Udo, Catriona Goodlad, Andrew Davenport
Journal of Nephrology|June 8, 2026
The impact of reducing dialysate flows during haemodiafiltration and haemodialysis sessionsGareth Murcutt, Catriona Goodlad, Andrew Davenport
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 3, 2010
Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanningCatriona Goodlad, Ruth Tarzi, Wladyslaw Gedroyc, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 6, 2024
Dosing lutetium Lu 177-dotatate for a hemodialysis patientLindsay Taylor, Richard Meades, Ann-Marie Quigley, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 4, 2014
Dialysate cytokine levels do not predict encapsulating peritoneal sclerosisCatriona Goodlad, Frederick W K Tam, Sohail Ahmad, et al.
Kidney International|May 4, 2020
Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitisCatriona Goodlad, Sophiamma George, Shella Sandoval, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Postgraduate Medical Journal|August 3, 2013
The role of peritoneal dialysis in modern renal replacement therapyCatriona Goodlad, Edwina Brown
Seminars in Nephrology|March 29, 2011
Encapsulating peritoneal sclerosis: what have we learned?Catriona Goodlad, Edwina A Brown
American Journal of Nephrology|June 1, 2017
Impact of Diabetes on Extracellular Volume Status in Patients Initiating Peritoneal DialysisAniema Udo, Catriona Goodlad, Andrew Davenport
Journal of Nephrology|June 8, 2026
The impact of reducing dialysate flows during haemodiafiltration and haemodialysis sessionsGareth Murcutt, Catriona Goodlad, Andrew Davenport
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 3, 2010
Screening for encapsulating peritoneal sclerosis in patients on peritoneal dialysis: role of CT scanningCatriona Goodlad, Ruth Tarzi, Wladyslaw Gedroyc, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 6, 2024
Dosing lutetium Lu 177-dotatate for a hemodialysis patientLindsay Taylor, Richard Meades, Ann-Marie Quigley, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 4, 2014
Dialysate cytokine levels do not predict encapsulating peritoneal sclerosisCatriona Goodlad, Frederick W K Tam, Sohail Ahmad, et al.
Kidney International|May 4, 2020
Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitisCatriona Goodlad, Sophiamma George, Shella Sandoval, et al.
Pageof 1